{
    "organizations": [],
    "uuid": "d0a4915c78a323abb25462f2a70821a61ce38f69",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-nuvo-pharmaceuticals-says-total-re/brief-nuvo-pharmaceuticals-says-total-revenue-was-4-4-mln-for-three-months-ended-march-31-2018-compared-to-7-0-mln-idUSFWN1SH0SM",
    "ord_in_thread": 0,
    "title": "BRIEF-Nuvo Pharmaceuticals Says Total Revenue Was $4.4 Mln For Three Months Ended March 31, 2018 Compared To $7.0 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 10 (Reuters) - Nuvo Pharmaceuticals Inc:\n* â„¢ ANNOUNCES 2018 FIRST QUARTER RESULTS * TOTAL REVENUE WAS $4.4 MILLION FOR THREE MONTHS ENDED MARCH 31, 2018 COMPARED TO $7.0 MILLION FOR THREE MONTHS ENDED MARCH 31, 2017\n* NET LOSS WAS $0.2 MILLION FOR THREE MONTHS ENDED MARCH 31, 2018 COMPARED TO NET INCOME OF $2.2 MILLION FOR THREE MONTHS ENDED MARCH 31, 2017 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T19:19:00.000+03:00",
    "crawled": "2018-05-11T12:50:08.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "nuvo",
        "pharmaceutical",
        "inc",
        "announces",
        "first",
        "quarter",
        "result",
        "total",
        "revenue",
        "million",
        "three",
        "month",
        "ended",
        "march",
        "compared",
        "million",
        "three",
        "month",
        "ended",
        "march",
        "net",
        "loss",
        "million",
        "three",
        "month",
        "ended",
        "march",
        "compared",
        "net",
        "income",
        "million",
        "three",
        "month",
        "ended",
        "march",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}